ID: ALA2041539

Max Phase: Preclinical

Molecular Formula: C13H22O2

Molecular Weight: 210.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC1CCC(C2CC3CCC2C3)CC1O

Standard InChI:  InChI=1S/C13H22O2/c14-12-4-3-10(7-13(12)15)11-6-8-1-2-9(11)5-8/h8-15H,1-7H2

Standard InChI Key:  SGUPAOBRTOEZCB-UHFFFAOYSA-N

Associated Targets(non-human)

Matrix protein 2 436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 210.32Molecular Weight (Monoisotopic): 210.1620AlogP: 1.94#Rotatable Bonds: 1
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.90CX Basic pKa: CX LogP: 1.76CX LogD: 1.76
Aromatic Rings: 0Heavy Atoms: 15QED Weighted: 0.69Np Likeness Score: 1.39

References

1. Wang J, Ma C, Balannik V, Pinto LH, Lamb RA, Degrado WF..  (2011)  Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus.,  (4): [PMID:21691418] [10.1021/ml100297w]

Source